A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
NCT00038025
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Peripheral T-cell Lymphoma
Cutaneous T-cell Lymphoma
Chronic Lymphocytic Leukemia
Interventions
DRUG:
Deoxycoformycin (DCF)
Sponsor
M.D. Anderson Cancer Center